Phenotypic and Metabolomic Characteristics of Mouse Models of Diet-Induced Hepatic Steatosis

Author:

Yang Cian-Ru1,Lin Wen-Jen1,Shen Pei-Chun1,Liao Pei-Yin1,Dai Yuan-Chang2,Hung Yao-Ching3,Lai Hsueh‐Chou3,Mehmood Shiraz1,Cheng Wei-Chung1,Ma Wen-Lung3

Affiliation:

1. China Medical University

2. Ditmanson Medical Foundation Chia-Yi Christian Hospital

3. China Medical University Hospital

Abstract

Abstract Background Nonalcoholic steatohepatitis (NASH) is metabolic disease that may progress to cirrhosis and hepatocellular carcinoma. Mouse models of diet-induced NASH, which is characterized by the high levels of fats, sugars, and cholesterol in diets, are commonly used in research. However, mouse models accurately reflecting the progression of NASH in humans remain to be established. Studies have explored the potential use of serological metabolites as biomarkers of NASH severity in relation to human NASH. Methods We performed a comparative analysis of three mouse models of diet-induced NASH in terms of phenotypic and metabolomic characteristics; NASH was induced using different diets: a high-fat diet; a Western diet; and a high-fat, high-cholesterol diet. Liver cirrhosis was diagnosed using standard clinical approaches (e.g., METAVIR score, hyaluronan level, and collagen deposition level). Mouse serum samples were subjected to nuclear magnetic resonance spectroscopy–based metabolomic profiling followed by bioinformatic analyses. Metabolomic analysis of a retrospective cohort of patients with hepatocellular carcinoma was performed; the corresponding cirrhosis scores were also evaluated. Results Using clinically relevant quantitative diagnostic methods, the severity of NASH was evaluated. Regarding metabolomics, the number of lipoprotein metabolites increased with both diet and NASH progression. Notably, the levels of very low-density lipoprotein (VLDL) and low-density lipoprotein (LDL) significantly increased with fibrosis progression. During the development of diet-induced NASH in mice, the strongest upregulation of expression was noted for VLDL receptor. Metabolomic analysis of a retrospective cohort of patients with cirrhosis indicated lipoproteins (e.g., VLDL and LDL) as predominant biomarkers of cirrhosis. Conclusions Our findings provide insight into the pathophysiology and metabolomics of experimental NASH and its relevance to human NASH. The observed upregulation of lipoprotein expression reveals a feedforward mechanism for NASH development that may be targeted for the development of noninvasive theranostics.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3